KindlyMD (NAKA) Competitors $6.35 -0.87 (-12.05%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NAKA vs. VMD, XGN, DCGO, EUDA, SERA, QIPT, CORBF, BNR, ATPC, and KDLYShould you be buying KindlyMD stock or one of its competitors? The main competitors of KindlyMD include Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), Burning Rock Biotech (BNR), Agape ATP (ATPC), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. KindlyMD vs. Its Competitors Viemed Healthcare Exagen DocGo EUDA Health Sera Prognostics Quipt Home Medical Global Cord Blood Burning Rock Biotech Agape ATP Kindly MD Viemed Healthcare (NASDAQ:VMD) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment. Which has stronger valuation and earnings, VMD or NAKA? Viemed Healthcare has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViemed Healthcare$224.26M1.05$11.27M$0.3019.77KindlyMD$2.47M18.78-$3.62M-$0.77-8.25 Which has more volatility and risk, VMD or NAKA? Viemed Healthcare has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, KindlyMD has a beta of 35.16, indicating that its share price is 3,416% more volatile than the S&P 500. Do institutionals and insiders hold more shares of VMD or NAKA? 74.2% of Viemed Healthcare shares are owned by institutional investors. 20.0% of Viemed Healthcare shares are owned by insiders. Comparatively, 40.8% of KindlyMD shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer VMD or NAKA? In the previous week, Viemed Healthcare had 3 more articles in the media than KindlyMD. MarketBeat recorded 3 mentions for Viemed Healthcare and 0 mentions for KindlyMD. Viemed Healthcare's average media sentiment score of 1.17 beat KindlyMD's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the media. Company Overall Sentiment Viemed Healthcare Positive KindlyMD Neutral Is VMD or NAKA more profitable? Viemed Healthcare has a net margin of 5.28% compared to KindlyMD's net margin of -177.01%. Viemed Healthcare's return on equity of 9.49% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets Viemed Healthcare5.28% 9.49% 7.14% KindlyMD -177.01%-146.26%-109.19% SummaryViemed Healthcare beats KindlyMD on 10 of the 13 factors compared between the two stocks. Get KindlyMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NAKA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAKA vs. The Competition Export to ExcelMetricKindlyMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.74M$7.18B$5.49B$9.52BDividend YieldN/A2.90%4.73%4.09%P/E Ratio-8.2564.1328.7823.81Price / Sales18.7833.83372.2066.04Price / CashN/A25.7735.4557.96Price / Book14.778.618.275.54Net Income-$3.62M$239.96M$3.25B$259.28M7 Day Performance-42.11%-5.48%-3.70%-4.64%1 Month Performance-51.60%-3.73%4.34%4.41%1 Year PerformanceN/A18.27%25.90%17.95% KindlyMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAKAKindlyMDN/A$6.35-12.0%N/AN/A$52.74M$2.47M-8.25N/AHigh Trading VolumeVMDViemed Healthcare2.8913 of 5 stars$6.26+0.5%N/A-13.6%$246.23M$224.26M20.871,179News CoveragePositive NewsUpcoming EarningsXGNExagen4.5404 of 5 stars$8.45+14.3%$9.00+6.5%+329.4%$157.41M$55.64M-10.06220Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionGap DownHigh Trading VolumeDCGODocGo2.9289 of 5 stars$1.42-4.7%$3.56+150.7%-61.8%$151.96M$520.50M-71.004,407News CoverageUpcoming EarningsEUDAEUDA Health0.9661 of 5 stars$3.28-0.6%N/A-14.6%$122.62M$4.01M0.002SERASera Prognostics0.5519 of 5 stars$2.90-7.6%N/A-67.1%$118.29M$80K-3.09120News CoverageUpcoming EarningsQIPTQuipt Home Medical2.036 of 5 stars$2.19+2.3%$2.85+30.1%-39.5%$92.97M$245.91M-10.431,200CORBFGlobal Cord BloodN/A$0.71+29.1%N/AN/A$86.30M$196.12M0.001,200BNRBurning Rock Biotech0.7914 of 5 stars$5.81-15.8%N/A-17.0%$74.25M$70.67M-3.071,390ATPCAgape ATP0.2818 of 5 stars$1.27-4.2%N/A-57.4%$66.53M$1.29M-2.1240News CoverageGap DownKDLYKindly MDN/A$10.59-3.5%N/A+332.3%$63.77M$2.47M-13.75N/AGap Down Related Companies and Tools Related Companies Viemed Healthcare Alternatives Exagen Alternatives DocGo Alternatives EUDA Health Alternatives Sera Prognostics Alternatives Quipt Home Medical Alternatives Global Cord Blood Alternatives Burning Rock Biotech Alternatives Agape ATP Alternatives Kindly MD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAKA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KindlyMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KindlyMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
